National Cancer Institute
Building 31, Room 10A49
31 Center Drive, MSC 2580
Bethesda,
MD 20892-2580
301-496-1550 (Voice)
301-496-7807 (FAX)
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors designed to accelerate the application of the best capabilities of nanotechnology to cancer. Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.